Planning committee

Mona Dagher, MD (Chair)
Danah Albreiki, MD
Kashif Baig, MD
Isabelle Brunette, MD
Ralf R. Buhrmann, MD
Toby Chan, MD
Varun Chaudhary, MD
Jean Deschênes, MD
Stephanie Dotchin, MD
Jim Farmer, MD
Jit Gohill, MD
Patrick Gooi, MD
Lisa Gould, MD
Cindy Hutnik, MD
Femida Kherani, MD
Irfan Kherani, MD
Micah Luong, MD
Nav Nijhawan, MD
Jason Noble, MD
Michael O’Connor, MD
Allan Slomovic, MD
Josh Teichman, MD
Vivian Yin, MD


Mona Harissi-Dagher, MD, FRCSC

Mona Harissi-Dagher, MD

Chair, 2020 COS Annual Meeting Planning Committee

Dr. Dagher is currently a professor of ophthalmology at the Université de Montréal, head of the cornea service and director of the cornea fellowship. She is on staff at CHUM where she teaches medical students, ophthalmology residents and cornea fellows. She is director of ophthalmology research at Centre Hospitalier de l’université de Montréal, and trains MSc and PhD students.

Dr. Mona Dagher completed her undergraduate degree at McGill University where she received the Hilda Diana Oakley scholarship for ranking top female student at McGill. She then completed her medical degree and specialization in ophthalmology at the Université de Montréal, graduating on the dean’s honor list. Dr. Dagher then pursued post-doctoral fellowship training in cornea, external eye diseases, and refractive surgery at the Massachusetts Eye and Ear Infirmary.

Dr. Dagher has brought her expertise on keratoprosthesis surgery to Canada after conducting considerable research and clinical work at Harvard Medical School under the mentorship of Dr Claes Dohlman.

After restoring sight to several Canadian patients through implantation of the Boson Keratoprosthesis, Dr. Dagher was chosen ‘Personality of the Week’ by La Presse newspaper and Radio-Canada.

Dr. Dagher has completed extensive research projects in the field of ophthalmology and more particularly, on the Boston Keratoprosthesis and on refractive surgery. Dr. Dagher has published numerous articles and acts as a reviewer for ophthalmology journals. She has also authored numerous book chapters on the subject of cornea and external eye diseases. Dr. Dagher has been a guest lecturer at ophthalmology conferences internationally.

Financial disclosure: Dr. Dagher does not have any affiliation (financial or otherwise) with a commercial organization.


Danah H. Albreiki, MD

Danah Albreiki, MD

Neuro-ophthalmology

Dr. Albreiki moved from Saudi Arabia to complete her residency training in Ophthalmology at the Ottawa University. She then proceeded with a subspecialty in Neuro-Ophthalmology and Adult Strabismus surgery at the Eye Institute under the mentorship of Dr. Vivek Patel in 2012. Dr. Albreiki is now an assistant professor at the Eye Institute. Dr. Albreiki has a passion for teaching, and was privileged to be the first to win the “Dr. William Clarke” medical teaching award two years in a row in 2015 and 2016.

Dr. Albreiki has a research interest in GCA and medical education. She is a member of the EYE VAN, the co-director of the ophthalmology undergraduate “Anglo stream” program, the co-advisor of the “ophthalmology interest group”, the founder of the “Mentor to inspire” mentorship program for the ophthalmology residents, and an examiner for the national and international Royal College of Physicians and Surgeons of Canada.

Financial disclosure: Dr. Albreiki does not have any affiliation (financial or otherwise) with a commercial organization.


Kashif Baig, MD, MBA, FRCSC

Kashif Baig, MD

Cornea

Dr. Baig is a cornea, anterior segment, and refractive surgeon providing tertiary level care at the University of Ottawa Eye Institute. He is an assistant professor at the University of Ottawa, pediatric cornea consultant at the Children’s Hospital of Eastern Ontario, principal investigator at the Ottawa Hospital Research Institute, and director of clinical and research fellowships in cornea, anterior segment, and refractive surgery. He is also the president of the Canadian Cornea, External Disease, and Refractive Surgery Society.

Dr. Baig completed his medical and residency training at McGill University, master of business administration degree (health services management) at McMaster University, and fellowship training in the United States. He has a strong interest in the development and implementation of surgical innovations in corneal and anterior segment surgery.

Financial disclosure: Dr. Baig has/had an affiliation (financial or otherwise) with a commercial organization:

  1. Allergan
  2. Labtician
  3. Santen


Isabelle Brunette, MD, FRCSC

Isabelle Brunette, MD

Ocular Regenerative Medicine

After completion of a clinical and research training in ophthalmology (Université de Montréal), corneal transplantation and corneal endothelium (Mayo Clinic, Rochester, MN), and refractive surgery (Emory Eye Clinic, Atlanta, GA), Dr. Brunette started her practice in 1990 as an ophthalmologist at Hôpital Maisonneuve-Rosemont (HMR), Montréal.

Dr. Brunette is full professor in the Department of Ophthalmology of the Université de Montréal. She is head of the Cornea Service at the HMR Department of Ophthalmology, head of Vision Health Research at the HMR Research Centre, and director of the Fonds de recherche du Québec – Santé’s Research in Vision Network. She has successively been member, vice-chair, and chair of the Institute Advisory Board for the Institute of Neuroscience, Mental Health and Addiction, Canadian Institutes of Health Research (CIHR).

As a clinician, the driving force behind her research comes from the patient. Her work is oriented toward translational research and is funded mainly by CIHR and the Natural Sciences and Engineering Research Council of Canada. Her research has been focusing on the optimization of the functional outcome of corneal transplantation, based on leading edge progress in the fields of tissue engineering, femtosecond laser and biomaterials technologies.


Ralf R. Buhrmann, MDCM, MPH, PHD, FRCSC

Ralf R. Buhrmann, MD

Global and Public Health Ophthalmology

Dr. Buhrmann is a glaucoma consultant at the University of Ottawa Eye Institute with a practice focus on the management and surgical treatment of glaucoma, cataract and complex cataract. Over the last 4 years he spearheaded the fundraising and development of a new Glaucoma Center at the University of Ottawa Eye Institute scheduled to open in the Spring of 2020.

Dr. Buhrmann received his medical school and ophthalmology residency training at McGill University. He completed a fellowship in preventive ophthalmology and a fellowship in glaucoma with Harry Quigley at the Wilmer Ophthalmological Institute at Johns Hopkins University where he also obtained a Master of Public Health and a PhD in Clinical Epidemiology.

Blindness prevention is a special interest of Dr. Buhrmann. From 1999 to 2001 he served as project director for the Kongwa Eye Project and Kongwa Investigation of Mortality and Sight in central Tanzania. In 2002 he founded the Canadian Association for Public Health and Global Ophthalmology (CAPHGO) where he continues to serve on the executive. He was lead author of Foundations for a Canadian Vision Health Strategy produced for the National Coalition for Vision Health in 2007. Dr. Buhrmann has spent 2 years working in Africa in Zimbabwe, Sierra Leone, Cameroon and Tanzania. He supervises the International Ophthalmology Electives Program at the University of Ottawa Eye Institute which provides senior residents with a subsidized three-week hands-on training in tropical ophthalmology and manual small incision cataract surgery in partnership with the Srikiran Institute of Ophthalmology in Andhra Pradesh, India.

Dr. Buhrmann is passionate about innovation in surgical teaching. He is a repeat winner of resident surgical teaching awards and is a sought-after mentor for surgical skills transfer courses nationally and internationally. He is the founding director of the Ophthalmic Surgical Simulation Center (OSSC) at the Ottawa Eye Institute. Over the last decade Dr. Buhrmann has been developing and teaching a rigorous competency-by-design pre-OR surgical skills training program for ophthalmology residents. The University of Ottawa has recognized his work with an Innovation in Medical Education Award.

He is a long serving member of the Annual Meeting Program Planning Committee for the Canadian Ophthalmological Society and has published numerous peer-reviewed articles and several book chapters.

Financial disclosure: Dr. Buhrmann has/had an affiliation (financial or otherwise) with a commercial organization:

  1. Allergen


Toby Chan, MD

Toby Chan, MD

Glaucoma

Dr. Chan is an assistant clinical professor (adjunct) of ophthalmology at the McMaster University. He has a glaucoma and anterior segment surgery practice as part of the Ocular Health Centre in Kitchener, Ontario. He received his medical degree at the University of Ottawa and completed residency at the University of Western Ontario. During residency, he received the Best Glaucoma Research Proposal Award from the Canadian Glaucoma Society, and achieved third place for the Canadian Ophthalmological Society Award for Excellence in Research. He completed a fellowship in Glaucoma and Advanced Anterior Segment Surgery at the University of Toronto, and most recently a two-year Emerging Leaders Program at the University of Toronto Rotman School of Business.

Dr. Chan served as co-chair of the glaucoma section planning committee at the Canadian Ophthalmological Society meeting in 2019, chair of the planning committee for the Canadian Glaucoma Society annual meeting in 2018, and was co-director of the glaucoma skills transfer course at the Canadian Ophthalmological Society annual meeting in 2017 and at the International Congress on Glaucoma Surgery in 2018. In addition to authoring 5 textbook chapters and 13 journal articles, he has given over 50 presentations in national and international conferences. His current research focus is in novel glaucoma treatment options, anterior segment reconstruction, and use of technologies in improving the patient experience and medical education.

Financial disclosure: Dr. Chan has/had an affiliation (financial or otherwise) with a commercial organization:

  1. Alcon
  2. Allergan
  3. Aequus
  4. Bausch + Lomb
  5. Johnson & Johnson Vision
  6. Labtician Thea
  7. Novartis


Varun Chaudhary, MD, FRCSC

Varun Chaudhary, MD

Retina

Dr. Chaudhary is a vitreo-retinal surgeon, chief of ophthalmology, and associate professor of surgery at Hamilton Regional Eye Institute, McMaster University.

As an educator, he acts as retina chair for the McMaster University ophthalmology residency training program and has been the recipient of the surgical and medical Teacher of the Year Award three times.

As a researcher, he has secured multiple peer-reviewed grants for research in tele-ophthalmology, age-related macular degeneration, diabetic retinopathy, and posterior segment drug delivery systems. He is the site principal investigator for the international DRCR network and sits on the steering committee for multi-national clinical trials in retina. Dr. Chaudhary supervises master’s level thesis students in translational retinal research and was appointed Associate Member, McMaster School of Biomedical Engineering.

He acts as editor-in-chief for the Canadian Journal of Ophthalmology. He was awarded the Senior Honor Award by the American Society of Retinal Specialists.

His administrative experience extends to the provincial level as regional physician lead for ophthalmology and as clinical advisor for multiple provincial ophthalmology working groups. At the national level, he acts as CPD director for the Canadian Retina Society and serves as a board member for the Canadian Retina Society.

Financial disclosure: Dr. Chaudhary has/had an affiliation (financial or otherwise) with a commercial organization:

  1. Alcon
  2. Bayer
  3. Novartis


Jean Deschênes, MD

Jean Deschênes, MD

Uveitis

Dr. Deschênes is professor of ophthalmology at McGill University. His main clinical and research interests are treating immune-related problems of the eye involving uveitis, cornea, and the anterior segment.

He was the first in the Department of Ophthalmology to become a Chercheur Boursier for the Fonds de Recherche en Santé du Québec for funds to support his work in ocular immunology. Thus, Dr. Deschênes set up a practice centre for seeing patients in ocular immunology dealing with uveitis, external disease and cornea.

In teaching, a new section of ophthalmology, concerning ocular immunology and uveitis, was set up, a facility that was unique in Quebec and Canada and became well known. With all of the developments in ocular immunology occurring at McGill, there were many publications and invitations for Dr. Deschênes to write chapters in prominent textbooks. From the research point of view, his and the research unit’s major contribution has been in the understanding of the normal immunology of the eye and the changes occurring in ocular inflammation.

In addition, over the years, innovative treatments were developed in the ocular immunology and AIDS clinics. Beyond the research done and treatments developed at the research ophthalmology immunology unit, it was not long after its creation that the unit began to produce additional ocular immunologists, with fellows and research trainees doing rotations under the direction of Dr. Deschênes. Many of the residents and fellows who worked with Dr. Deschênes are now well established in university centers in Canada, South America and the United States.

Ocular immunology has become an important part of the program for teaching clinical care and research. Its international reputation is growing, and McGill is known as a center where treatment of immune diseases of the eye is first rate with excellent research being done.

In addition to his work at McGill and its hospitals, Dr. Deschênes has also found time to be active in many professional associations including, among others, the Canadian Ophthalmological Society, the Association des Médecins Ophtalmologistes du Québec as president and the International Uveitis Study Group. He has also been an Associate Dean in the Faculty of Medicine and acted as the Residency Training Program Director. Dr. Deschênes is the Ophthalmologist-in-Chief at the McGill University Health Center (MUHC) in Montreal.

The university’s reputation as a leading centre in immune disease treatment and research can largely be attributed to Dr. Deschênes’ work. He is a first-rate teacher and role model for colleagues and students, combining clinical ophthalmology and research. A prodigious worker, it is fortunate that he is physically strong, a quality that he goes to great lengths to maintain, including having a gymnasium installed in the basement of his house. Despite being incredibly busy and in demand, he always finds time to talk to colleagues and residents. He is indeed a leader in his field and has brought luster to the McGill Department. That he can perform all of the duties of a clinician, as well as those of an internationally known researcher, is indeed remarkable.

Financial disclosure: Dr. Deschênes has/had an affiliation (financial or otherwise) with a commercial organization:

  1. Imprimis
  2. NIH/NEI
  3. ZEDS


Stephanie Dotchin, MD

Stephanie Dotchin, MD

Retina

Dr. Dotchin is clinical assistant professor at the University of Calgary, Section of Ophthalmology when she is a pediatric ophthalmologist. She completed her MD at the University of Saskatchewan (2005), followed by her residency at Dalhousie University (2010). Dr. Dotchin then went on to complete two fellowships, one at Moorfields Eye Hospital, London UK and the second at Children’s Hospital of Philadelphia. Dr. Dotchin then went on to join the staff at the University of Calgary.

Dr. Dotchin is involved in numerous boards and committees. She is currently serving on the Canadian Orthoptic Council, and is the current president of the Canadian Association of Pediatric Ophthalmology and Strabismus. She is president elect for the Eye Physicians and Surgeons of Alberta. Dr. Dotchin is a master teacher with the University of Calgary and heavily involved with residency education. Dr. Dotchin has special interests in various areas, including advocacy, retinopathy of prematurity and education.

Financial disclosure: Dr. Dotchin has/had an affiliation (financial or otherwise) with a commercial organization:

  1. Alcon
  2. Novartis


Jim Farmer, MD, FRCSC, FRCPC

Jim Farmer, MD

Pathology

Dr. Farmer is an adjunct associate professor of ophthalmology, and pathology and molecular medicine (cross appointment) at Queen’s University in Kingston, Ontario, and an assistant professor of laboratory medicine (anatomical pathology) with a cross appointment in ophthalmology at the University of Ottawa. He graduated from the University of Ottawa Medical School and completed his residency in ophthalmology at the University of Ottawa and then a Fellowship in pediatric ophthalmology, strabismus and pediatric neuro-ophthalmology with Drs. A. Jampolsky, A. Scott, and C. Hoyt at the Smith Kettlewell Institute of Visual Science in San Francisco, California, and the University of California, San Francisco. He completed a residency in anatomical pathology at the University of Vermont in Burlington, Vermont, and the University of Ottawa. He is section chair of the Canadian Ophthalmic Pathology Society and a member of the Eastern Ophthalmic Pathology Society based in the United States.

Financial disclosure: Dr. Farmer has/had an affiliation (financial or otherwise) with a commercial organization:

  1. CNIB Eye Van


Jit Gohill, MD

Jit Gohill, MD

Cataract Surgery

Dr. Gohill is a general ophthalmologist, practising in Calgary for the past 22 years. He did his PhD in immunology and graduated from the University of Calgary medical school in 1990. He is currently a clinical assistant professor at the University of Calgary where he continues to teach. He has won several teaching awards. He has a busy cataract and glaucoma practice.


Financial disclosure: Dr. Gohill has/had an affiliation (financial or otherwise) with a commercial organization:

  1. Alcon
  2. Allergan
  3. Bausch + Lomb
  4. Pfizer
  5. Shire


Patrick Gooi, MD

Patrick Gooi, MD

Surgical Skills Transfer Courses

Dr. Patrick Gooi is the glaucoma subsection lead and a clinical lecturer at the University of Calgary. He specializes in the surgical management of glaucoma, complex cataract, and anterior segment reconstruction.

Dr. Gooi is enthusiastically involved in medical education and innovation, being a western Canadian leader in novel glaucoma surgeries such as XEN, GATT, and iStent Inject. His group currently is the world leader in publications on the use of GoPRO® cameras in Medicine.

In addition to Dr. Gooi’s 18 publications, he has presented over 30 papers at national and international meetings such as the Canadian Ophthalmological Society and the American Academy of Ophthalmology. He served as the co-director for the Cataract Skills Transfer Course at the Canadian Ophthalmological Society Meeting 2018. He also sits on the Patient Care and Innovation Committee of the Canadian Glaucoma Society.

Financial disclosure: Dr. Gooi has/had an affiliation (financial or otherwise) with a commercial organization:

  1. Allergan
  2. Alcon
  3. Bausch & Lomb
  4. Glaukos
  5. Johnson & Johnson
  6. Labtician
  7. Santen


Lisa Gould, MD

Lisa Gould, MD

Glaucoma

Dr. Gould is an associate professor of ophthalmology at the University of Manitoba.

Dr. Gould obtained her medical degree from the University of Manitoba, and after an internship at the Victoria Hospital in London, Ontario, completed her residency in ophthalmology at the University of Toronto, followed by a glaucoma fellowship under the direction of Dr. Graham Trope.

In addition to a busy surgical and medical glaucoma practice, she enjoys teaching residents and fellows. She is currently involved in developing a professionalism curriculum for postgraduate medical education at the university, and is the residency glaucoma lead and the glaucoma fellowship director. Dr. Gould’s interest in Indigenous health has lead her to work in the past as a visiting consultant to Northern communities, as well as a consultant for the First Nations Inuit Health Branch.

Dr. Gould serves on several committees locally and nationally, including the Scientific Advisory Committee of the Glaucoma Research Society of Canada, and is Chair of the COS Steering Committee on Physician Wellness.

Financial disclosure: Dr. Gould has/had an affiliation (financial or otherwise) with a commercial organization:

  1. Bausch + Lomb
  2. Théa


Cindy M.L. Hutnik, MD, PhD, FRCSC

Cindy M.L. Hutnik, MD, PhD

Awards and Posters

Dr. Hutnik is a full professor in the Departments of Ophthalmology and Pathology at the Schulich School of Medicine and Dentistry. She served as medical director of the Ophthalmology Basic Science Laboratory at the Lawson Health Research Institute in the Centre for Clinical Investigation and Therapeutics for 18 years and chair of research in the Department of Ophthalmology for 15 years. She earned her doctoral degree at the National Research Council followed by undergraduate medical training, both in Ottawa, Canada. She then obtained her ophthalmology training at the University of Western Ontario, in London, Canada followed by subspecialty glaucoma training under the mentorship of Dr. Paul Kaufman at the University of Wisconsin, Madison, USA. She currently is a member of a number of editorial and research review boards. This includes medical education section editor for the Canadian Journal of Ophthalmology. She supervises an independent program of clinical, basic science, educational research and collaborates with local colleagues engaged in health economics research.

Her administrative roles have included faculty chair of the Summer Research Training Program at the University of Western Ontario as well as membership on the Faculty Clinician-Scientist Committee, Medical Advisory Committee of the Canadian National Institute for the Blind Mobile Eye Care Program, councilor of the Canadian Glaucoma Society and co-chair of the Canadian Glaucoma Clinical Research Council. She also served on the clinical expert panel for the creation of Ontario glaucoma quality standards. Currently, she is the provincial glaucoma representative on the Tariff Committee of the Eye Physician and Surgeons of Ontario, clinical advisor to the Canadian Agency for Drugs and Technologies in Health (CADTH) and recently elected as the chair of the National Poster Award Committee of the Canadian Ophthalmological Society.

Her major research interest is focused on the pathophysiology and management of glaucoma with a sub-interest in ocular surface and macular disease. She has supervised and mentored in research more than 250 students at all levels of training ranging from high school to graduate science and medicine. Her work has been presented and published both nationally and internationally and has been recognized with over 70 awards. She continues to have keen interest in the development of novel and/or optimization of existing treatments for patients with glaucoma. In addition to research she is engaged in a number of initiatives such as an objective model of competency based medical education, a multi-level microsurgical instruction course, collaborative models of eye care and global partnerships between the Schulich School and key centres in China.

Financial disclosure: Dr. Hutnik has/had an affiliation (financial or otherwise) with a commercial organization:

  1. Alcon
  2. Allergan
  3. Novartis


Femida Kherani, MD, FRCSC, DIPLOMATE ABO, FASOPRS

Femida Kherani, MD

Women in Ophthalmology




Irfan N. Kherani, AB, MD

Irfan N. Kherani, AB, MD

Ophthalmology Residents

Irfan Kherani is a fourth year ophthalmology resident at the University of Ottawa, where he is currently Chief Resident. He is presently serving as vice-president of the Council of Canadian Ophthalmology Residents and recently completed his term as chair of the Board of the Resident Doctors of Canada (RDoC) and Resident Council Member on the Medical Council of Canada (MCC).

Dr. Kherani grew up in Edmonton, Alberta, and completed his secondary schooling at Lester B. Pearson United World College of the Pacific. In 2011, he graduated from Princeton University with an undergraduate degree in molecular biology with certificates in global health and health policy as well as theatre arts. During his undergraduate medical training, Irfan served as president of the University of Alberta Medical Students’ Association and executive vice-president of the Canadian Federation of Medical Students.

He is interested in medical education, specifically how we can optimize the implementation of competency-based medical education, as well as the role of electroretinography in the assessment of pre-perimetric glaucoma.

Financial disclosure: Dr. Kherani does not have any affiliation (financial or otherwise) with a commercial organization.


Micah Luong, MD

Vision Rehabilitation

Financial disclosure: Dr. Luong does not have any affiliation (financial or otherwise) with a commercial organization.


Nav Nijhawan, MD, FRCSC, DABO

Nav Nijhawan, MD

Oculoplastics

Dr. Nijhawan graduated from the University of Toronto Medical School and completed his residency in ophthalmology there. He received the American Society of Ophthalmic Plastic and Reconstructive Surgery Fellowship at the University of Toronto, which he completed in 2003.

Dr. Nijhawan is a speaker and educator on topics related to ophthalmic plastic and reconstructive surgery and is actively involved in teaching medical students, residents and fellows. He is an assistant professor of ophthalmology at the University of Toronto and McMaster University and is on staff at St. Michael’s Hospital in Toronto and Lakeridge Health in Oshawa. In 2012, he was awarded the University of Toronto’s Department of Ophthalmology Golden Suture Award for resident surgical teaching.

In 2011, he was one of the co-authors who were awarded the American Society of Ophthalmic Plastic and Reconstructive Surgery Research Award for his paper on “Lymphatic drainage patterns of the human eyelid.”

Dr. Nijhawan is also actively involved in promoting more effective and efficient eye care within the province and in the past has been the chair of the Eye Physician and Surgeons of Ontario and is a current member of the Eye Health Council of Ontario.

Financial disclosure: Dr. Nijhawan does not have any affiliation (financial or otherwise) with a commercial organization.


Jason Noble, MD

Retina

Dr. Noble is an ophthalmologist and medical retina specialist. He is board certified in ophthalmology in Canada and the USA. He attended the University of Toronto for his residency training in ophthalmology and then pursued a fellowship in medical retina and diabetic eye disease at the Department of Ophthalmology, Harvard Medical School, training at the Massachusetts eye and Ear infirmary and the Joslin diabetes center. Dr. Noble is a staff consultant at Sunnybrook Health Sciences Centre and Markham-Stouffville Hospital, and is an assistant professor at the University of Toronto Department of Ophthalmology and Vision Sciences. He is actively involved in medical education and clinical research.

Financial disclosure: Dr. Noble has/had an affiliation (financial or otherwise) with a commercial organization:

  1. Bayer
  2. Novartis


Michael O’Connor, MD, MSc, FRCSC

Michael O’Connor, MD

Pediatrics

Dr. O’Connor completed his master’s (1997) and medical degrees (2001) at Queen’s University in Kingston. He completed residency training at the University of Ottawa in 2006, followed by a fellowship in paediatric ophthalmology and strabismus at the Hospital for Sick Children in Toronto. In 2007, joined the Department of Ophthalmology in Ottawa, dividing his time between pediatric and adult practice.

Dr. O’Connor has a broad range of interests. He has served as the president of the Canadian Orthoptic Council (2012-2015) and president of the Canadian Association of Pediatric Ophthalmology and Strabismus (2017-2019). From 2007 to 2016, he directed the preclerkship undergraduate ophthalmology anglophone teaching at the University of Ottawa Medical School. Among his distinctions for excellence in clinical teaching at the post-graduate teaching level, he is a three-time recipient of the PARO Teaching Award. He is currently the department chief of ophthalmology at CHEO and is the director for the Paediatric Ophthalmology and Strabismus Fellowship.

Financial disclosure: Dr. O’Connor has/had an affiliation (financial or otherwise) with a commercial organization:

  1. Bayer
  2. Santen


Allan Slomovic, MD

Allan Slomovic, MD

Ocular Regenerative Medicine

Dr. Slomovic is vice chair of education and continuing education director for the Department of Ophthalmology and Vision Sciences at the University of Toronto. He is also the clinical director of the Cornea/External Disease Service at the Toronto Western Hospital, University Health Network. He is the past president of the Canadian Ophthalmologic Society and previous chair of the Canadian Cornea and External Disease Society for the Canadian Ophthalmological Society. Dr Slomovic is a professor of ophthalmology at the University of Toronto and the Marta and Owen Boris Endowed Chair in Cornea and Stem Cell Research at the University Health Network.

Prior to starting medical school, Dr. Slomovic completed a master’s degree in clinical psychology at the University of Montreal. He then went on to do his medical school training at Memorial University in St. John’s Newfoundland, followed by an internship in internal medicine at the Montreal General Hospital. Dr. Slomovic then o completed a 3-year residency training program at the New York University School of Medicine in Manhattan, New York. This was followed by two separate Fellowship programs at the Bascom Palmer Eye Institute in Miami, Florida. The first fellowship was in cornea/external ocular diseases and the second was in laser microsurgery.

Dr. Slomovic has been involved with teaching residents and fellows, research, and clinical practice over the past 30 years at the University Health Network. He was the program director for ophthalmology for the University of Toronto for 10 years (1991-2001) and has led the program through two successful Royal College reviews. He has also trained in cornea/external ocular diseases of the eye 45 fellows from all over the world, including Canada, United States, Israel, Australia, Singapore, Malaysia, Thailand, the Philippines, and Great Britain. In 2001, Dr. Slomovic was awarded the Mentor of the Year Award by the Royal College of Physicians of Canada. Dr. Slomovic is the inaugural winner of this award in the province of Ontario. Dr Slomovic has published numerous articles in the area of cornea/external diseases of the eye and refractive surgery and has also lectured on these topics locally, nationally, and internationally.

On March 2014, Dr. Slomovic was nominated by Toronto Life as one of Toronto’s best doctors.

Financial disclosure: Dr. Slomovic has/had an affiliation (financial or otherwise) with a commercial organization.

  1. Aequus
  2. Alcon Canada
  3. Allergan
  4. Bausch and Lomb
  5. Labtician /Thea
  6. Santen
  7. Shire


Josh Teichman, MD, MPH, FRCSC

Josh Teichman, MD

Cataract Surgery

Dr. Josh Teichman received his bachelor of science degree from Queen’s University then a doctor of medicine from Western University. He completed a residency in ophthalmology at McMaster University, a research fellowship at the University of Toronto, a master of public health focusing on clinical epidemiology and biostatistics, and a surgical fellowship in cornea, external disease, anterior segment and refractive surgery at the University of Ottawa. Dr. Teichman has won numerous awards from the AAO, the ASCRS, and the Canadian Ophthalmological Society.

Dr. Teichman holds a faculty position at the University of Toronto where he is a cornea fellowship preceptor, is actively involved in the teaching of fellows, residents, and medical students, and has received an award from Trillium Health Partners recognizing his teaching. Dr. Teichman is a section editor at the Canadian Journal of Ophthalmology and is in private practice at Prism Eye Institute and TLC Mississauga.

Financial disclosure: Dr. Teichman have/had an affiliation (financial or otherwise) with a commercial organization:

  1. Aequus
  2. Alcon
  3. Allergan
  4. Bausch & Lomb
  5. Labtician Théa
  6. Santen
  7. Shire


Vivian Yin, MD

Vivian Yin, MD

Global and Public Health Ophthalmology

Dr. Vivian T. Yin is a leading surgeon, researcher and teacher in ophthalmic plastic and reconstructive surgery. She worked at Memorial Sloan Kettering Cancer Center in New York and now returns to the University of British Columbia as assistant professor in the Division of Oculoplastics and Orbit. She focuses on the treatment of periocular and orbital cancer, especially the use of targeted therapy, and speaks internationally on these topics. After completing her medical degree and ophthalmology residency at the University of Toronto, she pursued a prestigious 2-year fellowship training in Ophthalmic Plastics and Reconstructive Surgery at the University of Texas M.D. Anderson Cancer Center in Houston, Texas.

Dr. Yin also has a special interest in global health and leadership with a Master in Public Health from the Johns Hopkins Bloomberg School of Public Health. She generously donates her spare time to work towards eliminating preventable blindness. She has traveled to Bangladesh, the Philippines, Nepal, Tunisia and India to teach and provide surgical care for those in need. Since 2014, she has been a member of the board of director for Seva Canada and is currently chair of the board.

Financial disclosure: Dr. Yin does not have any affiliation (financial or otherwise) with a commercial organization.